Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

BACKGROUND: Incretin therapy is feasible in patients with type 2 diabetes mellitus undergoing hemodialysis (HD). However, few studies have examined the safety and efficacy of this therapeutic approach in patients with diabetes and renal impairment. Here, we examined glycemic control and the anti-oxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Terawaki, Yuichi, Nomiyama, Takashi, Takahashi, Hiroyuki, Tsutsumi, Yoko, Murase, Kunitaka, Nagaishi, Ryoko, Tanabe, Makito, Kudo, Tadachika, Kobayashi, Kunihisa, Yasuno, Tetsuhiko, Nakashima, Hitoshi, Yanase, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438630/
https://www.ncbi.nlm.nih.gov/pubmed/25995772
http://dx.doi.org/10.1186/s13098-015-0043-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438630/
https://www.ncbi.nlm.nih.gov/pubmed/25995772
http://dx.doi.org/10.1186/s13098-015-0043-2

Ejemplares similares